The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. (2016)
Attributed to:
Precision Medicine Exeter Innovation Platform (PMEI Platform): Proof of Concept Funds
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.phrs.2016.08.019
PubMed Identifier: 27565382
Publication URI: http://europepmc.org/abstract/MED/27565382
Type: Journal Article/Review
Volume: 113
Parent Publication: Pharmacological research
Issue: Pt A
ISSN: 1043-6618